SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Pocock NA, Eisman JA, Hopper JL, Yeates MG, Sambrook PN, Ebert S 1987 Genetic determinants of bone mass in adults: a twin study. J Clin Invest 80: 706710.
  • 2
    Slemenda CW, Christian JC, Williams CJ, Norton JA, Johnston CC Jr 1991 Genetic determinants of bone mass in adult women: a reevaluation of the twin model and the potential importance of gene interaction on heritability estimates. J Bone Miner Res 6: 561567.
  • 3
    Howard GM, Nguyen TV, Harris M, Kelly PJ, Eisman JA 1998 Genetic and environmental contributions to the association between quantitative ultrasound and bone mineral density measurements: a twin study. J Bone Miner Res 13: 1318327.
  • 4
    Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, Sambrook PN, Eisman JA 1994 Prediction of bone density from vitamin D receptor alleles. Nature 367: 284287.
  • 5
    Tokita A, Matsumoto H, Morrison NA, Tawa T, Miura Y, Fukamauchi K, Mitsuhashi N, Irimoto M, Yamamori S, Miura M, Watanabe T, Kuwabara Y, Yabuta K, Eisman JA 1996 Vitamin D receptor alleles, bone mineral density and turnover in premenopausal Japanese women. J Bone Miner Res 11: 10031009.
  • 6
    Arai H, Miyamoto K, Taketani Y, Yamamoto H, Iemori Y, Morita K, Tonai T, Nishisho T, Mori S, Takeda E 1997 A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women. J Bone Miner Res 12: 915921.
  • 7
    Harris SS, Eccleshall TR, Gross C, Dawson-Hughes B, Feldman D 1997 The vitamin D receptor start codon polymorphism (Fok I) and bone mineral density in premenopausal American black and white women. J Bone Miner Res 12: 10431048.
  • 8
    Kobayashi S, Inoue S, Hosoi T, Ouchi Y, Shiraki M, Orimo H 1996 Association of bone mineral density with polymorphism of the estrogen receptor gene. J Bone Miner Res 11: 306311.
  • 9
    Grant SFA, Reid DM, Blake G, Herd R, Fogelman I, Ralston SH 1996 Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type Iα1 gene. Nat Genet 14: 203205.
  • 10
    Uitterlinden AG, Burger H, Huang Q, Yue F, McGuigan FEA, Grant SFA, Hofman A, van Leeuwen JPTM, Pols HAP, Ralston SH 1998 Relation of alleles of the collagen type Iα1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women. N Engl J Med 338: 10161021.
  • 11
    Shiraki M, Shiraki Y, Aoki C, Hosoi T, Inoue S, Kaneki M, Ouchi Y 1997 Association of bone mineral density with apolipoprotein E phenotype. J Bone Miner Res 12: 14381445.
  • 12
    Hosoi T, Miyao M, Inoue S, Hoshino S, Shiraki M, Orimo H, Ouchi Y 1999 Association study of parathyroid hormone gene polymorphism and bone mineral density in Japanese postmenopausal women. Calcif Tissue Int 64: 205208.
  • 13
    Langdahl BL, Knudsen JY, Jensen HK, Gregersen N, Eriksen EF 1997 A sequence variation: 713-8delC in the transforming growth factor-beta 1 gene has higher prevalence in osteoporotic women than in normal women and is associated with very low bone mass in osteoporotic women and increased bone turnover in both osteoporotic and normal women. Bone 20: 289294.
  • 14
    Yamada Y, Miyauchi A, Goto J, Takagi Y, Okuizumi H, Kanematsu M, Hase M, Takai H, Harada A, Ikeda K 1998 Association of a polymorphism of the transforming growth factor-β1 gene with genetic susceptibility to osteoporosis in Japanese women. J Bone Miner Res 13: 15691576.
  • 15
    Matsuyama T, Ishii S, Tokita A, Yabuta K, Yamamori S, Morrison NA, Eisman JA 1995 Vitamin D receptor genotypes and bone mineral density. Lancet 345: 12381239.
  • 16
    Dawson-Hughes B, Harris SS, Finneran S 1995 Calcium absorption on high and low calcium intakes in relation to vitamin D receptor genotype. J Clin Endocrinol Metab 80: 36573661.
  • 17
    Han KO, Moon IG, Kang YS, Chung HY, Min HK, Han IK 1997 Nonassociation of estrogen receptor genotypes with bone mineral density and estrogen responsiveness to hormone replacement therapy in Korean postmenopausal women. J Clin Endocrinol Metab 82: 991995.
  • 18
    Oursler MJ, Cortese C, Keeting P, Anderson MA, Bonde SK, Riggs BL, Spelsberg TC 1991 Modulation of transforming growth factor-β production in normal human osteoblast-like cells by 17β-estradiol and parathyroid hormone. Endocrinology 129: 33133320.
  • 19
    Finkelman RD, Bell NH, Strong DD, Demers LM, Baylink DJ 1992 Ovariectomy selectively reduces the concentration of transforming growth factor β in rat bone: Implications for estrogen deficiency- associated bone loss. Proc Natl Acad Sci U S A 89: 1219012193.
  • 20
    Hughes DE, Dai A, Tiffee JC, Li HH, Mundy GR, Boyce BF 1996 Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-β. Nat Med 2: 11321136.
  • 21
    Tau KR, Hefferan TE, Waters KM, Robinson JA, Subramanian M, Riggs BL, Spelsberg TC 1998 Estrogen regulation of a transforming growth factor-β inducible early gene that inhibits deoxyribonucleic acid synthesis in human osteoblasts. Endocrinology 139: 13461353.
  • 22
    Finkelman RD, Linkhart TA, Mohan S, Lau K-HW, Baylink DJ, Bell NH 1991 Vitamin D deficiency causes a selective reduction in deposition of transforming growth factor β in rat bone: Possible mechanism for impaired osteoinduction. Proc Natl Acad Sci U S A 88: 36573660.
  • 23
    Sterck JG, Klein-Nulend J, Burger EH, Lips P 1996 1,25-Dihydroxyvitamin D3-mediated transforming growth factor-β release is impaired in cultured osteoblasts from patients with multiple pituitary hormone deficiencies. J Bone Miner Res 11: 367376.
  • 24
    Boyan BD, Schwartz Z, Park-Snyder S, Dean DD, Yang F, Twardzik D, Bonewald LF 1994 Latent transforming growth factor-β is produced by chondrocytes and activated by extracellular matrix vesicles upon exposure to 1,25-(OH)2D3. J Biol Chem 269: 2837428381.
  • 25
    Yanagisawa J, Yanagi Y, Masuhiro Y, Suzawa M, Watanabe M, Kashiwagi K, Toriyabe T, Kawabata M, Miyazono K, Kato S 1999 Convergence of transforming growth factor-β and vitamin D signaling pathways on SMAD transcriptional coactivators. Science 283: 13171321.
  • 26
    Yamada Y, Hosoi T, Makimoto F, Tanaka H, Seino Y, Ikeda K 1999 Transforming growth factor beta-1 gene polymorphism and bone mineral density in Japanese adolescents. Am J Med 106: 477479.
  • 27
    Shiraki M, Fukunaga M, Morita R, Orimo H 1991 Cross calibrated standard values of vertebral bone mineral density in Japanese. J Bone Miner Metab 9: 4449.
  • 28
    Orimo H, Sugioka Y, Fukunaga M, Muto Y, Hotokebuchi T, Gorai I, Nakamura T, Kushida K, Tanaka H, Ikai T, Oh-hashi Y 1998 Diagnosis criteria of primary osteoporosis. J Bone Miner Metab 16: 139150.
  • 29
    Riggs BL, Seeman E, Hodgson SF, Taves DR, O'Fallon WM 1982 Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. N Engl J Med 306: 446450.
  • 30
    Bonewald LF 1996 Transforming growth factor-β. In: BilezikianJP, RaiszLG, RodanGA (eds.) Principles of Bone Biology. Academic Press, San Diego, CA, U.S.A., pp. 647659
  • 31
    Oursler MJ 1994 Osteoclast synthesis and secretion and activation of latent transforming growth factor β. J Bone Miner Res 9: 443452.
  • 32
    Noda M, Camilliere JJ 1989 In vivo stimulation of bone formation by transforming growth factor-β. Endocrinology 124: 29912994.
  • 33
    Derynck R, Jarrett JA, Chen EY, Eaton DH, Bell JR, Assoian RK, Roberts AB, Sporn MB, Goeddel DV 1985 Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature 316: 701705.
  • 34
    Verner K, Gottfried S 1988 Protein translocation across membranes. Science 241: 13071313.
  • 35
    Geiser AG, Zeng QQ, Sato M, Helvering LM, Hirano T, Turner CH 1998 Decreased bone mass and bone elasticity in mice lacking the transforming growth factor-β1 gene. Bone 23: 8793.
  • 36
    Orimo H, Shiraki M, Hayashi Y, Hoshino T, Onaya T, Miyazaki S, Kurosawa H, Nakamura T, Ogawa N 1994 Effects of 1α-hydroxyvitamin D3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis. Calcif Tissue Int 54: 370376.
  • 37
    Aloia JF, Vaswani A, Yeh JK, Ellis K, Yasumura A, Cohn SH 1988 Calcitriol in the treatment of postmenopausal osteoporosis. Am J Med 84: 401408.
  • 38
    Gallagher JC, Goldgar D 1990 Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. Ann Intern Med 113: 649655.
  • 39
    Tilyard MW, Spears GFS, Thomson J, Dovey S 1992 Treatment of postmenopausal osteoporosis with calcitriol or calcium. N Engl J Med 326: 357362.
  • 40
    Nicolas V, Prewett A, Bettica P, Mohan S, Finkelman RD, Baylink DJ, Farley JR 1994 Age-related decreases in insulin-like growth factor-I and transforming growth factor-β in femoral cortical bone from both men and women: implications for bone loss with aging. J Clin Endocrinol Metab 78: 10111016.
  • 41
    Easrell R 1998 Treatment of postmenopausal osteoporosis. N Engl J Med 338: 736746.